The International Symposium onMultidetector-Row CT (2007)
Session I: Technology: Present and Future
Course Introduction | Geoffrey D. Rubin |
Building Blocks of MDCT: The Big Picture | Geoffrey D. Rubin |
High Definition MDCT: Initial Clinical Experience | W. Dennis Foley |
Advanced Sampling Strategies for High Spatial Resolution and Reduced Aliasing Artifacts | Norbert J. Pelc |
Dual Source CT: How Does it Work and What Can it Do? | Cynthia H.McCollough |
Source CT:What is the Best Temporal Resolution and When is it Unattainable? | Willi Kalender |
256-row CT: Challenges and Advantages for Clinical Implementation | Kazuhiro Katada |
C-arm CT Imaging: Image Quality and Dose Considerations | Rebecca Fahrig |
Introducing Advanced MDCT Clinical Applications in Your Practice: Understanding the Gap | Jay Cinnamon |
Introducing Advanced MD-CT Clinical Applications in Your Practice: Strategic Planning and Pragmatic Implementation | Jay Cinnamon |
Session II: Radiation Exposure
CT of the Pregnant Patient: When to Worry About Fetal Dose | Cynthia H.McCollough |
Dose Considerations for Dual Source CT Systems | Willi Kalender |
Radiation Dose in Cardiac Imaging: How Does CT Compare? | Cynthia H.McCollough |
Significant Dose Reduction in Coronary CTA Using Prospectively ECG-Gated Axial “Step and Shoot” Scans (SnapShotPulseTM) with 64-Slice MDCT | Sachio Kuribayashi |
Discussion |
Session III: Contrast Medium Delivery and Risk Management
Early Arterial Contrast Medium Dynamics: The Facts and the Myths | Justus E. Roos |
How Fast Can and Should Contrast Medium Be Injected? | Dominik Fleischmann |
Cardiac CTA: Bolus Shaping and Physiologic Contrast Saline Mixing in the SVC | W. Dennis Foley |
Integrated Scanning and Injection Protocols: The Paradigm Shift with 64-Channel MDCT | Dominik Fleischmann |
Is it Necessary to Hydrate Patients with Chronic Kidney Disease Before Contrast Enhanced CT Exams? | Richard Solomon |
-Induced Nephropathy: Efficacy of Intra-Renal Delivery of Prophylactic Vasodilators and Anti-Oxidant Therapy | James A. Tumlin |
Update on Contrast Agents and Nephrotoxicity: Results of the Latest Clinical Trials | Richard Solomon |
Nephrogenic Sclerosing Fibrosis: A Nephrologist Perspective in a Rare and Complicated Disorder. | James A. Tumlin |
Discussion |
Session IV: Pediatrics
Pediatric CT Should Be Carried Out at Lower Energies | Willi Kalender |
Roles and Risks of General Anesthesia in Children Undergoing Cardiac CT | Frandics Chan, MD, PhD |
Challenges of MDCT in Congenital Heart Disease | Dianna M. E. Bardo |
MDCTA for the Follow Up of Congenital Heart Disease | S. Bruce Greenberg |
Unsuspected Pathology Discovered on ECG-Gated 64-Detector-Row MDCT in Patients with Congenital Heart Disease | John Hauschildt |
MDCTA in Children Other Than Congenital Heart Disease | S. Bruce Greenberg |
Thymus - Normal and Abnormal | Beverley Newman |
Modern Work-Up of Possible Vascular Rings and Slings One-Stop Shopping Using MDCT | John Hauschildt |
MDCT for Congenital Anomalies (How to Use CT to Evaluate Anomalies of the Airway, Bones, etc.) | S. Bruce Greenberg |
CT Imaging for Pulmonary Infection in Childhood | Beverley Newman |
CT Versus Psychiatric Treatment in Girls with Urinary Dribbling | Richard A. Barth |
Congenital Lung Anomalies Understanding Hybrid Lesions | Beverley Newman |
The Role of CT in Diagnosis of UPJ Obstruction | Richard A. Barth |
Discussion |
Session V: Trauma/Musculoskeletal
MDCT of the Musculoskeletal System | Lawrence N. Tanenbaum |
Musculoskeletal MDCT: Simple But Effective Protocols | Christopher F. Beaulieu |
VR of the Soft Tissues: Techniques and Pathology | Elliot K. Fishman |
Important Issues in the Characterization of Hip and Pelvis Fractures | Christopher F. Beaulieu |
Extremity CT Angiography in Trauma: Benefits of 64 MDCT | Jorge A. Soto |
The Temporal Dimension: Value of Delayed Imaging in MDCT of Trauma and Abdominal Pathology | Terry S. Desser |
MDCT of Active Arterial Bleeding Post-Trauma: The Clinical Significance of an Expanding Hematoma | R. Brooke Jeffrey |
MDCT of Diaphragmatic Rupture | Terry S. Desser |
Discussion |
Session VI: Abdomen I: Liver, Pancreas, and Kidneys
Microangiopathic Changes in the Liver and their Impact on Contrast Enhancement Patterns | Dushyant Sahani |
MDCT of the Biliary Tree:What is the Role? | Michael Macari |
CT Perfusion Imaging Outside Stroke | Mathias Prokop |
Perfusion CT of the Liver and Tumor Angiogenesis | Dushyant Sahani |
Post RF Ablation The Good, the Bad and the Ugly | Darren Brennan |
MDCT of the Pancreatic Duct | Jorge A. Soto |
Islet Cell Tumors of the Pancreas: Spectrum of MDCT Findings | R. Brooke Jeffrey |
Can We Make a Confident Diagnosis of a Cystic Pancreatic Lesion at MDCT? | Michael Macari |
“The Virtual Whipple” -- The Use of MDCT and Advanced Rendering for Comprehensive Preoperative Assessment of the Pancreas | Darren Brennan |
MDCT Renal Cell Cancer Imaging: Monitoring Antiangiogenetic Therapy - Including Perfusion CT Applications | Anno Graser |
Designing an Optimal Technique for MDCT Urography | F. Graham Sommer |
MDCT with CTA and CT Urography for Evaluation of Transitional Cell Carcinoma | Elliot K. Fishman |
CT Urography - The Latest Views | F. Graham Sommer |
Is There a Need for Dual Energy CT in Abdominal Imaging? | Anno Graser |
Discussion |
Session VII: Abdomen II: Bowel
When to Use Positive and Neutral Oral Contrast at CT Enterography | Michael Macari |
CT Enterography - 3D Workstation Interpretation | Matthew A. Barish |
Potential Pitfalls of CT Enterography | Michael Macari |
Acute Abdominal Pain with 64 MDCT: Is Oral Contrast Necessary? | Jorge A. Soto |
Subtle Bowel and Mesenteric Injuries on MDCT | R. Brooke Jeffrey |
Minimal Preparation CT Colonography: Definitions and Issues for Implementation | Michael Zalis |
Advanced Visualization Techniques in Virtual Colonoscopy | Matthew A. Barish |
Advanced Electronic Cleansing for Non-Cathartic Multi-Detector CT Colonography | Michael Zalis |
Why CAD Will Be Important in CT Colonography Interpretation | Christopher F. Beaulieu |
Computer Aided Detection in Non-Cathartic Multi-Detector CT Colonography | Michael Zalis |
Reducing False Positives in Virtual Colonoscopy Interpretation | Matthew A. Barish |
CT Colonography: Key Recent Studies | Christopher F. Beaulieu |
The Munich Colorectal Cancer Prevention Trial | Anno Graser |
Discussion |
Session VIII: Workflow/Image Processing
Software Guided Evaluation of Tumor Response (WHO, RECIST, Perfusion, PET, etc...) | Christoph R. Becker |
Tips for Quality Assurance in Post Processing | Laura Pierce |
3D-Lab in a Community Radiology Practice | Jay Cinnamon |
3D Techs - Now That You’ve Trained Them, How Do You Retain Them? | Laura Pierce |
Client Server Models: Impact on Operations | Elliot K. Fishman |
Effective Networking: the Critical Pathway From Scan to Report | Paul J. Chang |
Advanced Processing Functions Separate Workstations vs. PACS Integration: How to Choose | Jeffrey B.Mendel |
3D Workstations in the PACS Environment One Year Later: Are There Any Dirty Little Secrets Left? | Bart L. Dolmatch |
What Should We Expect From PACS and 3D Workstations in the Next Three Years | Paul J. Chang |
Future Visualization Tools | Sandy Napel |
Discussion |
Session IX: Chest
Strategy for Reducing Radiation Dose for Chest CT | Hiroto Hatabu |
Small Pulmonary Nodules: A Pragmatic Approach to Management | Ann N. Leung |
Perifissural Lung Nodules - What to Make of Them? Cornelia | Schaefer-Prokop |
Ground Glass Nodules: What are They and Should They be Managed Differently than Solid Nodules? | Ella A. Kazerooni |
Lung Cancer Screening: Is Mortality Affected? | Ann N. Leung |
What is the Significance of Pulmonary Nodules in Patients with Extrathoracic Malignancy | Fergus Gleeson |
Is Lung Nodule CAD Finally Ready for Prime Time? | Jeffrey B.Mendel |
Lung CAD:When is it Enough and When is it Too Much? | Justus E. Roos |
Do Radiologists Benefit From Lung CAD Equally? | Geoffrey D. Rubin |
CAD Requires Just a Dab of Dose | Patrik Rogalla |
Nodule Evaluation:When is PET Useful? | Ann N. Leung |
Utility of Dual Time Point PET/CT Imaging | Andrew Quon |
How to Determine Significant Growth of a Pulmonary Nodule | Cornelia Schaefer-Prokop |
The Ins and Outs of Long Nodule Volumetry for Differentiating Between Benign and Malignant Disease | Mathias Prokop |
Nodule Segmentation: The Radiologist is Superfluous | Patrik Rogalla |
Does Growth Reflect Malignant Potential in Pulmonary Nodules Detected on CT | Fergus Gleeson |
Volume HRCT vs. Discontinuous HRCT of the Lung: Where is the Added Value? Cornelia | Schaefer-Prokop |
What’s New in CT for Pulmonary Embolism? U. | Joseph Schöpf |
How to Maximize Contrast Enhancement in CT Pulmonary Angiography: Mitigating the PFO Effect | Ella A. Kazerooni |
MDCT for the Breast: Adjunct to Breast MRI | Jeffrey B.Mendel |
Discussion |
Session X: Neuro
The Radiological Evaluation of Cerebrovascular Disease:When to Use MRA, US, CTA, Catheter Angiography? | Jay Cinnamon |
Speed Bumps: Diagnostic Risks with 64- Slice Speed | Megan K. Strother |
MDCT Assessment of Aneurysms | Nancy J. Fischbein |
State-of-the-Art Neuro-CTA in a High Volume Clinical Practice: Using a 3D Lab to Realize the “Ultrasound” Workflow Paradigm | Stuart R. Pomerantz |
Essentials of Neurovascular CTA Post-Processing:What’s New? | Michael H. Lev |
3D Post-Processing of Neuro-CTA (Bone Removal and Vessel Region Segmentation): A New Workflow Paradigm? | Stuart R. Pomerantz |
CTA/MRA Surveillance of Patients with Treated Neurovascular Disease (e.g., Clips, Coils, Stents) | Lawrence N. Tanenbaum |
MDCT in dx of Dural AV Fistulas | Nancy J. Fischbein |
Discussion | |
“Vulnerable Plaque” and Stroke Risk: Under-Rated or Over-Valued? | Michael H. Lev |
CT versus MR for Perfusion Imaging of Cerebral Ischemia | Megan K. Strother |
Whole Brain CT Perfusion Using 256-Rows Area Detector CT | Kazuhiro Katada |
Stroke Thrombolysis Beyond 3-hours?: Patient Selection with CTA/CTP | Michael H. Lev |
How to Launch a Brain Attack Perfusion Program in a Community Practice | Jay Cinnamon |
Breathe or Not to Breathe: Optimizing Air Flow and Air Contrast in MDCT of the Neck | Megan K. Strother |
MDCT vs. MR in Assessment of Craniocervical Dissection | Nancy J. Fischbein |
CTA of Blunt Neck Trauma:When is it Indicated? | Michael H. Lev |
the Twisted Spine: Advanced MDCT Post-Processing Techniques for Degenerative & Traumatic Spinal Disease | Stuart R. Pomerantz |
Discussion |
Session XI: Vascular
Velocity Compensated CTA of the Thoracoabdominal Aorta | W. Dennis Foley |
Subtraction CT Angiography with 256-Rows Area Detector CT | Kazuhiro Katada |
Arterial Occlusive Disease: Gadolinium-Enhanced MR, Unenhanced MR, or Minimal Iodine Dose CT in Patients with Stage 4 Renal Failure | Robert J. Herfkens |
Aortic Dissection:What is Type A,What is Type B, and Why is it Not Enough ? | Dominik Fleischmann, MD |
Aortic Inflammatory Conditions:What are They and What are the CTA Findings? | Bart L. Dolmatch |
Ulcer-Like Lesions of the Aorta | Dominik Fleischmann |
CTA of Endoleaks | Terri J. Vrtiska |
CT Venography: Methods, Indications, and Applications | Anne Chin |
Renal Artery CTA: Donors to Dissections | Terri J. Vrtiska |
CTA/MRA of the Peripheral Vasculature: When and Where | Lawrence N. Tanenbaum |
Dual Energy CTA of Supraaortic Arteries and Arteries of the Lower Extremity | Christoph R. Becker |
Dual Energy CT of Peripheral Arterial Disease with Single-Source 64-Slice MDCT | Sachio Kuribayashi |
Discussion |
Session XII: Cardiac I: Technique, Indications, and Interpretationt
Cardiac CT Protocols (Includes PT Prep, Pharmacology, and Actual Protocols) | Charles S.White |
Prospectively Gated Axial CT: Techniques and Patient Selection | James P. Earls |
Rate Control and Radiation Protection at Cardiac 64-Slice and Dual-Source CT | U. Joseph Schöpf |
Rate Control and Radiation Protection at Cardiac 64-Slice and Dual-Source CT | Christoph R. Becker |
Gated Axial (PGA) Coronary CT Angiography: How to Achieve an 80% Radiation Dose Reduction with Improved Image Quality | James P. Earls |
How to Deal with Cardiac Arrhythmia in Gated CT Acquisition | Frandics Chan |
Cardiac CT Without the Need for an ECG -- The Kymogram Approach | Willi Kalender |
Dual Source MDCT: Its Advantages and Limitations | Gilbert Raff |
Dual Source CT Coronary Artery Angiography: Do We Still Care about High Heart Rates? | Harald Seifarth |
Temporal Resolution for Non-Invasive Coronary Imaging: How Much Do We Need? | Martin H. K. Hoffmann |
The Value of Whole Organ Coverage for Cardiac Imaging | Martin H. K. Hoffmann |
Coronary CT Angiography Using 256-Rows Area Detector CT | Kazuhiro Katada |
Discussion |
Session XIII: Cardiac I: Cardiac PET/CT and Non-Coronary Applications
Contrast Material, Breathing, and Heart Beat:Why PET-CT of the Heart is More Complicated than CT and PET of the Heart | Harald Seifarth |
Cardiac PET/CT: The True One-Stop Shop? | Marcelo F. Di Carli |
Myocardial Perfusion by Cardiac CTA | James K.Min |
Evaluation of CAD: Anatomy or Perfusion? | Marcelo F. Di Carli |
Assessment of Global and Regional Cardiac Function Using Dual Source CT: Are We There? | Harald Seifarth |
Method and Rationale for Aortic Valve Assessment with MDCT | Elsie Nguyen |
Structured Cardiac CT Report Part Three: Cardiac Function | Ella A. Kazerooni |
Prior to Ablation of Atrial Fibrillation:What is Important? | James K.Min |
The Use of MDCT in Acute Chest Pain | Gilbert Raff |
MDCT for Chest Pain in the ED | Charles S.White |
Triage of Patients Suspected Acute Coronary Syndrome using 64-slice MDCT | Sachio Kuribayashi |
CT-Angiographic Patterns of CAD in Patients with Acute Chest Pain | Udo Hoffmann |
Dealing with Coronary Calcium | James P. Earls |
Discussion |
Session XIV: Cardiac II: Coronary CTA - Detection and Characterization
Calcium Scoring for Coronary Risk Assessment on Non-Gated Chest CT | Mathias Prokop |
Measurement of Coronary Calcification in Chronic Hemodialysis Patients: Emerging Role in the Management of Secondary Hyperparathyroidism | James A. Tumlin |
Structured Cardiac CT Report Part One: Calcium Scoring | Ella A. Kazerooni |
Coronary CTA: Coronary Anatomy and Terminology - A Cardiologist ‘s Perspective | Julie M.Miller |
Discrimination of the “Significant” Plaque and Coronary Artery Stenosis | Dianna M. E. Bardo |
Identification of Plaque Patterns by Coronary CTA Predicts Ischemia | James K. Min |
Diagnostic Accuracy Coronary CTA Comparing CT: Is Diagnostic Cath Dying? | Julie M. Miller |
Coronary CTA: Inter Observer Agreement on Stenosis Sizing | W. Dennis Foley |
Prognostic Value of Cardiac CT Angiography for Prediction of All-Cause Mortality | James K. Min |
The Detection of Coronary Artery Stenosis by Cardiac MDCT From Single Center Studies to Multi Center Trials to Clinical Reality | Udo Hoffmann |
Multicenter Clinical Trials in CTA:Why? | Julie M. Miller |
Studies of Coronary CTA: The Missing Link | Geoffrey D. Rubin |
Discussion | |
There a Role for CTA of the Coronaries in Asymptomatic High Risk Patients? | Mathias Prokop |
Biomarkers and Coronary Plaque and Stenosis What Works Better in Patients with Acute Chest Pain? | Udo Hoffmann |
Coronary Artery Plaque Analysis: Can We Go Beyond Calcium Quantification? | Harald Seifarth |
Plaque Imaging:What Role Will CT Play in the Scenario of Molecular Imaging? | Martin H. K. Hoffmann |
MDCT of Cardiac Bypass Grafts and Stents | Charles S.White |
Evidence for the Appropriateness of MDCT Use in 2007 | Gilbert Raff |
Structured Cardiac CT Report Part Two: Coronary Arteries | Ella A. Kazerooni |
Extravascular Findings on CTA Exams | Terri J. Vrtiska |
Managing the Non Cardiac Part of the Coronary CT Exam | Ella A. Kazerooni |
The Wild,Wild West of Cardiac CTA Credentialing and What Physicians Need to Know | Bart L. Dolmatch |
Discussion |
End